AtomVie Global Radiopharma
AtomVie Global Radiopharma specializes in GMP manufacturing and global distribution of radiopharmaceuticals, offering a range of services and collaborating with Isotopia to enhance the supply of lutetium-177.
Services
AtomVie Global Radiopharma offers a range of services in the radiopharmaceutical sector. These include Process & Analytical Method Development & Validation, Quality Operations, Regulatory support, Clinical Supply, Commercial Supply, Isotope Supply, and Logistics. The company specializes in the GMP manufacturing and global distribution of radiopharmaceuticals, ensuring compliance with industry standards and efficiency in product delivery.
Collaborations
AtomVie Global Radiopharma is collaborating with Isotopia to enhance the global supply of lutetium-177 (Lu-177), a popular radioisotope used in targeted radiotherapy. This partnership aims to bolster the availability and distribution of Lu-177, supporting the needs of healthcare providers and patients around the world.
Facility Expansion
AtomVie Global Radiopharma is currently constructing a new state-of-the-art GMP manufacturing facility in Hamilton, Ontario. Scheduled for commissioning in 2024, this multi-product facility will significantly increase production capacity, with the potential for over 10 times the output of the current facility. The new site will meet Canadian, US, and EU GMP requirements, ensuring it complies with the highest standards in radiopharmaceutical manufacturing.
Global Distribution
AtomVie Global Radiopharma has a robust global distribution network, delivering radiopharmaceuticals to over 15 countries daily. The company services regions across North America, South America, Europe, Asia, Africa, and Australia, ensuring timely and reliable product delivery to meet the diverse needs of its international customer base.